Treatment for rare diseases- an ethical imperative
Rare diseases impact a relatively small cohort of population which makes them a cost intensive category for pharmaceutical companies as well as the national governments. By Dr. Nalini Kaushik, World Rare Disease Day – 28th Feb: COVID-19 pandemic exposed the world to ethical imperatives of equitable access to health products. While this was a demand-based … Read more